According to Incyte's latest financial reports the company's total liabilities are $1.59 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-12-31 | $1.59 B | 8.25% |
2022-12-31 | $1.47 B | 26.43% |
2021-12-31 | $1.16 B | 22.5% |
2020-12-31 | $0.94 B | 14.64% |
2019-12-31 | $0.82 B | 15.08% |
2018-12-31 | $0.71 B | 7.12% |
2017-12-31 | $0.67 B | -44.88% |
2016-12-31 | $1.21 B | 45.78% |
2015-12-31 | $0.83 B | -4.76% |
2014-12-31 | $0.87 B | 6.74% |
2013-12-31 | $0.82 B | 62.78% |
2012-12-31 | $0.50 B | -9.11% |
2011-12-31 | $0.55 B | -3.84% |
2010-12-31 | $0.57 B | -29.03% |
2009-12-31 | $0.81 B | 79.81% |
2008-12-31 | $0.45 B | 4.12% |
2007-12-31 | $0.43 B | -0.75% |
2006-12-31 | $0.43 B | 11.44% |
2005-12-31 | $0.39 B | -10.24% |
2004-12-31 | $0.43 B | 94.66% |
2003-12-31 | $0.22 B | -9.82% |
2002-12-31 | $0.24 B | -5.89% |
2001-12-31 | $0.26 B |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
Novartis NVS | $53.19 B | 3,240.83% | ๐จ๐ญ Switzerland |
Pfizer PFE | $137.21 B | 8,517.45% | ๐บ๐ธ USA |
Eli Lilly LLY | $53.14 B | 3,237.54% | ๐บ๐ธ USA |
Amgen AMGN | $90.92 B | 5,610.21% | ๐บ๐ธ USA |
Ligand Pharmaceuticals LGND | $86.3 M | -94.58% | ๐บ๐ธ USA |
Geron GERN | $0.14 B | -90.82% | ๐บ๐ธ USA |
CTI BioPharma
CTIC | $0.13 B | -91.36% | ๐บ๐ธ USA |
AVEO Oncology
AVEO | $72.38 M | -95.45% | ๐บ๐ธ USA |
Ardelyx ARDX | $0.13 B | -91.79% | ๐บ๐ธ USA |